IRIS - Res&Arch Institutional Research Information System - Research & Archive

GORACCI, Gianfrancesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.668
EU - Europa 2.281
AS - Asia 635
Continente sconosciuto - Info sul continente non disponibili 5
AF - Africa 2
OC - Oceania 2
SA - Sud America 2
Totale 5.595
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.660
UA - Ucraina 620
IE - Irlanda 529
SE - Svezia 377
HK - Hong Kong 233
IT - Italia 229
SG - Singapore 155
FI - Finlandia 120
DE - Germania 116
CN - Cina 103
RU - Federazione Russa 89
GB - Regno Unito 81
KR - Corea 46
VN - Vietnam 45
TR - Turchia 37
BE - Belgio 36
CH - Svizzera 21
FR - Francia 17
AT - Austria 12
UZ - Uzbekistan 10
PL - Polonia 9
GR - Grecia 7
EU - Europa 5
CA - Canada 4
CZ - Repubblica Ceca 4
NL - Olanda 3
BR - Brasile 2
ES - Italia 2
IM - Isola di Man 2
JP - Giappone 2
MX - Messico 2
NZ - Nuova Zelanda 2
RS - Serbia 2
AL - Albania 1
BD - Bangladesh 1
BS - Bahamas 1
DZ - Algeria 1
EE - Estonia 1
IN - India 1
IR - Iran 1
LB - Libano 1
MU - Mauritius 1
NO - Norvegia 1
PR - Porto Rico 1
PT - Portogallo 1
RO - Romania 1
Totale 5.595
Salva come PNG Salva come JPEG
Città #
Chandler 665
Dublin 529
Jacksonville 323
San Mateo 237
Hong Kong 233
Ann Arbor 165
Medford 111
Princeton 108
Singapore 100
Wilmington 93
Ashburn 76
Andover 59
Dong Ket 45
Seoul 45
Des Moines 39
Beijing 37
Izmir 37
Brussels 35
Perugia 31
Woodbridge 29
Altamura 26
Saint Petersburg 26
Houston 25
Auburn Hills 20
Lawrence 19
New York 17
Norwalk 16
Rome 16
Falls Church 15
Boardman 14
Helsinki 12
Los Angeles 10
Shanghai 10
Città Di Castello 8
Milan 8
Moscow 6
Grugliasco 5
Redwood City 5
Busto Arsizio 4
Cisterna di Latina 4
Edinburgh 4
Southend 4
Den Haag 3
Frankfurt Am Main 3
Tappahannock 3
Acquasparta 2
Andria 2
Belgrade 2
Casalbordino 2
Castagnaro 2
Douglas 2
Favara 2
Kraków 2
London 2
Miami 2
Ottawa 2
Padova 2
Phoenix 2
Redmond 2
San Giovanni Valdarno 2
San Paolo di Civitate 2
Simi Valley 2
Aci Sant'antonio 1
Atlanta 1
Auckland 1
Barge 1
Bedlington 1
Bracciano 1
Campodarsego 1
Casalecchio Di Reno 1
Cassano Delle Murge 1
Castelfranco Veneto 1
Castellana Grotte 1
Cattolica 1
Chicago 1
Costa Mesa 1
Costabissara 1
Cremona 1
Dearborn 1
Delhi 1
Forino 1
Fremont 1
Gazipur 1
Goiânia 1
Gore 1
Guangzhou 1
Guidonia 1
Hefei 1
Hendon 1
Kashan 1
Kunming 1
Lausanne 1
Legnago 1
León 1
Lisbon 1
Madrid 1
Messina 1
Mira 1
Modena 1
Montreal 1
Totale 3.352
Salva come PNG Salva come JPEG
Nome #
L’infiltrazione intradetrusoriale di tossina botulinica A riduce i livelli tissutali vescicali di nerve growth factor in pazienti affetti da iperattività detrusoriale neurogena. 173
Activation of human platelet phospholipase A2 induced by phisiological agonist or fluoroaluminate: effec of inhibitors of protein kinases 122
Misurazione del PAF (fattore attivante le piastrine) nella saliva umana; standardizzazione del metodo 106
Activation of phospholipase A2 and B-thromboglobulin release in human platelets: comparative effects of thrombin and fluoroaluminate stimulation. 105
Characterization of nuclear secretory phospholipase A2 (sPLA2) 95
Studio di un'attività fosfolipasica presente nei nuclei di cellule gliali e neuronali di corteccia cerebrale di ratto. 94
Mitochondrial localization of sPLA2-IIA in neuronal cell 90
The induction of long-term potentiation (LTP) in the medial vestibular nuclei enhances the activities of enzymes involved in the synthesis of platelet-activating-factor (PAF). 88
Is isoprostane 8-iso-PGF2a a reliable marker of different velico-sphincter dysfunction? 83
Properties of phospholipase A2 in the nuclear fraction of rat brain cortex 81
Characterization of a phospholipase A2 present in purified nuclei from rat brain cortex . INTERNATIONAL CONFERENCE ON PHOSPHOLIPASE A2 80
Immunolocalization of secretory phospholipases A2 (sPLA2) in neural cells 80
RELEASE OF GROUP IIA SECRETORY PHOSPHOLIPASE A2 FROM RAT BRAIN MITOCHONDRIA: DOES IT CORRELATE WITH THAT OF CYTOCHROME c? 80
Phospholipase A2 activity in rat brain nuclei. 75
PAF-synthesizing enzyme activities increase during long-term potentiation in the rat medial vestibular nuclei 74
Rat brain release a phospholipase A2 having properties similar those of the typr II secretory enzymes 73
Localisation and properties of Phospholipases A2 in rat brain cortex mithocondria assayed with labelled E.Coli membranes as substrates. 70
Protein kinase C inhibitors enhance G-protein induced phospholipase A2 activation in intact human platelets 70
The release of arachidonic acid (AA ) by human platelets stimulated by fluoroaluminate and low concetration of collagene potentiated by inhibitors of protein kinase C (PKC). 68
The synthesis of choline and etrhanolamine phosphoglycerides in neuronal and glial cells of rabbit in vitro. 68
Release of group IIA secretory phospholipase A2 from rat brain mitochondria: does it correlated with that of cytochrome c? 68
Down-regulation of fluoroaluminate-induced release of arachidonic acid by protein kinase C is calcium-dependent and not related to secretory phospholipase A2 67
Platelet activating factor : a potential retrograde messenger in long term potentiation of the rat medial vestibular nuclei. 67
The presence of a secretory phospholipase A2 in the nuclei of neuronal and glial cells of rat brain cortex. 66
EFFECT OF NGF ON PHOSPHOLIPASES A2 LOCALIZATION IN PC12 CELLS 65
NGF Induces the Expression of Group IIA Secretory Phospholipase A2 in PC12 Cells: The Newly Synthesized Enzyme Is Addressed to Growing Neurites 65
Analysis by high performance liquid chromatography of the water-soluble precursors of choline and ethanolamine phosphoglycerides in the rat brain 64
Cloricromene inhibits G-Protein mediated activation of phospholipase A2 in human platelets 60
Bladder tissue levels of nerve growth factor in patients with benign prostatic hyperplasia and detrusor overactivity treated with tamsulosin. 58
Group II phospholipase A2 (GIIA) is involved in neuritogenesis in NGF-treated PC12 cells. 58
High pressure liquid chromatography (HPLC) of water-soluble precursors of choline and ethanolamine phosphoglycerides in animal tissues 57
Determination of nerve growth factor levels into human bladder wall by modified enzyme-linked immunoabsorbent assay. 56
Brain secretory phospholipase A2: functions and roles in neurodegenerative diseases 56
Lipid metabolism during early ischemia 56
Botulinum A toxin intravesical treatment induces a reduction of nerve growth factor bladder tissue levels in patients with neurogenic detrusor overactivity. 55
Characterization of a Phospholipases A2 present in purified nuclei from brain cortex 55
Secretory phospholipases A2 in neural cells: localization and functions 54
Bladder tissue levels of NGF in SCI patients with detrusor overactivity before and after botulinum-A toxin injections into the detrusor muscle 54
Nerve Growth Factor bladder tissue levels in patients with benign prostatic hyperplasia and detrusor overactivity treated with tamsulosin. 54
Role of Platelet activating factor in the long term potentiation of the rat medial vestibular nuclei. 54
Characterization of rat brain phospholipases A2 and their possible role in cellular signaling 54
The presence of a secretory phospholipase A2 in the nuclei of neuronal and glial cells of rat brain cortex 53
Brain secreted phospholipases A2 (sPLA2) as intra- and extra-cellular mediators 53
Fusion of human platelets with cytidine-5-phospate loaded liposomes: effect on arachidonic acid release. 53
Enzymic synthesis of 1-alkyl-2-acyl-sn-glycero-3-phosphorylethanolamine through ethanolaminephosphotransferase activity in the neuronal and glial cells of rabbit in vitro 53
Immunolocalization of secretory phospholipases A2 (sPLA2) in neural cells 53
Effect of protein kinase inhibitors on HFS-induced long term potentiation and activation of PAF-synthesizing enzymes in rat medial vestibular nuclei. 52
Presence of Group V Phospholipase A2 in rat brain cortex nuclei. 52
Trattamento dei disturbi vescicali sensitivi con tossina botulinica A: studio pilota 51
Reversible inhibition of hydrogen peroxide elimination by calcium in brain mitochondria 51
Enhancement of PAF-synthesizing enzyme activities during long-term potentiation (LTP) in rat brain-stem slices 51
Subcellular localization of secretory phospholipases A2 (sPLA2) group IIA (GIIA) and group V (GV) in neural cells 51
Brain mitochondrial phospholipases A2: functions and role in cell death 50
Platelet-activating factor and group I metabotropic glutamate receptors interact for full development and maintenance of long-term potentiation in the rat medial vestibular nuclei. 50
Choline plasmalogen biosynthesis by transmethylation in human platelets 50
Group IIA secretory phospholipase A2 (GIIA) mediates apoptotic death during NMDA receptor activation in rat primary cortical neurons. 49
Brain secretory phospholipases A2: role in neurodegeneration. 49
The effects of Calcium on reactive oxygen species elimination in brain mitochondria 49
Effect of NGF on the Subcellular Localization of Group IIA Secretory Phospholipase A2 (GIIA) in PC12 Cells: Role in Neuritogenesis. 49
Properties of phospholipase A2 in the nuclear fraction of rat brain cortex. European Society of Neurochemistry and International Society of Neurochemistry (ESN-ISN) 48
Botulinum A toxin intradetrusorial injections modulate the bladder expression of NGF, TRKA, P75 and TRPV1 in patients with detrusor overactivity. 48
Involvment of group IIA phospholipase A2 (GIIA) in NGF-induced neuritogenesis of PC12 cells 47
The metabolism of labelled ethanolamine in neuronal and glial cells of the rabbit in vivo. 47
Is the cytosolic phospholipase A2 the enzyme that is activated by a G- protein-mediated mechanism in human platelets and is down-regulated by protein kinase C ? 47
The bladder urothelium: passive permeability and intravesical drug passive diffusion. 47
Determination of Nerve Growth Factor levels into human bladder wall by modified enzyme-linked immunoabsorbent assay. 46
Nerve Growth factor bladder tissue levels in patients with neurogenic detrusor overactivity before and after botulinum-A toxin injections into the detrusor muscle 46
Botulinum-A toxin injections into the detrusor muscle reduce nerve growth factor bladder tissue levels in patients affected by neurogenic detrusor overactivity. 46
Group B streptococcus (GBS) causes macrophage PLA2s activation and modification of phosphatidyl- serine metabolism during induction of apoptosis 46
Cholinephosphotransferase activity in human platelet 46
BOTULINUM-A TOXIN INJECTIONS INTO THE DETRUSOR MUSCLE REDUCE NERVE GROWTH FACTOR BLADDER TISSUE LEVELS IN P A TIENTS AFFECTED BY NEUROGENIC DETRUSOR OVER- ACTIVITY 45
Enzymic synthesis of ethanolamine plasmalogens through ethanolaminephospho-transferase activity in neurons and glial cells of rabbit in vitro 45
Mitochondrial and nuclear secretory phospholipases A2: potential partecipation to life or death decision of neural cells. 44
Protein kinase C inhibitors enhance G-protein induced phospholipase A2 activation in intact human platelets 44
Distribution of secretory phospholipase A2 (PLA2) in neural cells 44
PAF levels in saliva are regulated by inflammatory cells 44
Respiratory state and release of mitochondrial phospholipase A2 43
Inhibition of PAF synthesis by stimulated human polymorphonuclear leucocytes with cloricromene, an inhibitor of phospholipase A2 activation 41
Platelet-activating factor: role in long-term potentiation and in brain damage 41
Respiratory state and release of mitochondrial phospholipase A2. 40
Membrane phosphatidylcholine pools and synthetic mechanisms. 40
Phospholipase A2 release from rat brain cortex mitochondria depends on respiratory state and precedes the liberation of cytochrome c 40
CHARACTERIZATION OF NUCLEAR SECRETORY PHOSPHOLIPASE A2 (sPLA2) 40
Metabolic studies on ethanolamine phosphoglycerides in neuronal and glial cells. 38
Low Molecular Weight Phospholipases A2 in Mammalian Brain and Neural Cells: Roles in Functions and Dysfunctions 38
Role of Platelet-Activating Factor in long-term potentiation of the medial vestibular nuclei. 38
Release of a phospholipase a2 from rat brain mithocondria. 38
Livelli tissutali vescicali di Nerve Growth Factor nella Ipertrofia Prostatica Benigna ed iperattività detrusoriale dopo terapia con Tamsulosina. 36
Cloricromene inhibits leukotriene formation by human polymorphonuclear leukocytes by suppressing arachidonate release from membrane phospholipids. 36
Metabolism and functions of Platelet-Activating Factor in the nervous tissue. 36
Metabolism and functions of phosphatidylserine in mammalian brain. 36
Low molecular weight phospholipases A2 in mammalian brain and neural cells: roles in functions and dysfunctions. 35
Evidence that cytosolic phospholipase A2 is down-regulated by protein kinase C in intact human platelets stimulated with fluoroaluminate. 35
Presence of Group V Phospholipase A2 in rat brain cortex nuclei 35
Botulinum-A toxin injections into the detrusor muscle decrease nerve growth factor bladder tissue levels in patients with neurogenic detrusor overactivity 35
Localization and effect of ammodytoxin in PC12 cells. 32
Livelli tissutali di Nerve growth factor nella ipertrofia prostatica benigna ed iperattività detrusoriale dopo terapia con tamsulosina. 31
Neural Lipids 31
The effect of calcium on reactive oxygen species elimination in brain mitochondria 31
Role of protein kinase C in the release of arachidocic acid from platelets 31
Totale 5.594
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.281
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.281
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020508 8 6 87 11 81 5 94 5 105 39 4 63
2020/20211.123 6 100 51 108 299 79 93 8 143 49 109 78
2021/2022961 25 192 30 68 43 12 19 259 12 33 99 169
2022/20231.779 141 203 27 187 136 209 2 100 682 4 61 27
2023/2024669 34 69 31 6 10 9 174 24 91 7 135 79
2024/202547 47 0 0 0 0 0 0 0 0 0 0 0
Totale 5.799